Here's Why You Should Hold Avanos Medical (AVNS) Stock Now
Zacks Investment Research | Mar 04, 2020 06:30AM ET
Avanos Medical, Inc. (NYSE:AVNS) is likely to gain from a solid fourth-quarter show, while sluggishness in the Acute Pain business is a concern.
Shares of this company have declined 34.6% against the industry ’s 0.9% rise in a year’s time. The current level also compares unfavorably with the S&P 500 index’s 9.6% rise over the same time frame.
This $1.56-billion medical technology company currently has a Zacks Rank #3 (Hold). Avanos’ earnings are expected to grow 13.3% in the first quarter of 2020. Also, the company has a trailing four-quarter positive earnings surprise of 0.1%, on average.
Let’s take a closer look at the factors that are working in favor of the company right now.
Q4 Earnings & Positive Developments
Avanos reported adjusted earnings per share (EPS) of 34 cents in fourth-quarter 2019, which rose by a penny year over year.
Revenues totaled $189.8 million, up 11.7% on a year-over-year basis.
AVANOS MEDICAL, INC. Price and Consensus
.
Stryker’s long-term earnings growth is expected at 11.9%. The stock has a Zacks Rank #2.
Accuray’s fiscal fourth-quarter earnings is expected to skyrocket 200%.
IDEXX Laboratories’ first-quarter earnings growth is projected at 5.1%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.